HCA Q4 revenue $18.3B, EPS $5.63; 2025 EPS guidance $24.05-$25.85; $10B buyback authorized

HCA Healthcare, Inc.

2024-FY EPS reported $22.00 revenue$70,603,000,000

Q4 revenue $18.285B (+5.7% YoY); net income $1.438B ($5.63 diluted EPS) vs $1.607B ($5.93) in 4Q23; includes $0.60/sh hurricane impact.
Adjusted EBITDA Q4 $3.712B vs $3.618B; same-facility admissions +3.0%, equivalent admissions +3.1%.
Full year 2024 revenue $70.6B, net income $5.76B ($22.00 EPS) vs $5.24B ($18.97) in 2023; Adjusted EBITDA $13.88B.
2025 guidance: revenue $72.8-$75.8B, net income $5.85-$6.29B, EPS $24.05-$25.85, capex $5.0-$5.2B.
Board authorized $10B share repurchase; quarterly dividend $0.72/share payable Mar 31 to record Mar 17.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.